دورية أكاديمية

Noncoding RNA in Cholangiocarcinoma.

التفاصيل البيبلوغرافية
العنوان: Noncoding RNA in Cholangiocarcinoma.
المؤلفون: Salati, M, Braconi, C
المساهمون: Braconi, Chiara
بيانات النشر: THIEME MEDICAL PUBL INC
سنة النشر: 2019
المجموعة: The Institute of Cancer Research (ICR): Publications Repository
مصطلحات موضوعية: Humans, Cholangiocarcinoma, Bile Duct Neoplasms, Liver Neoplasms, MicroRNAs, Gene Expression Regulation, Neoplastic, Tumor Microenvironment, RNA, Long Noncoding, Carcinogenesis
الوصف: Cholangiocarcinomas (CCAs) are tumors with a dismal prognosis. Early diagnosis is a key challenge because of the lack of specific symptoms, and the curability rate is low due to the difficulty in achieving a radical resection and the intrinsic chemoresistance of CCA cells. Noncoding RNAs (ncRNAs) are transcripts that are not translated into proteins but exert their functional role by regulating the transcription and translation of other genes. The discovery of the first ncRNA dates back to 1993 when the microRNA (miRNA) lin-4 was discovered in Caenorhabditis elegans. Only 10 years later, miRNAs were shown to play an oncogenic role in cancer cells and within 20 years miRNA therapeutics were tested in humans. Here, the authors review the latest evidence for a role for ncRNAs in CCA and discuss the promise and challenges associated with the introduction of ncRNAs into clinical practice.
نوع الوثيقة: article in journal/newspaper
وصف الملف: Print-Electronic; 25; application/pdf
اللغة: English
تدمد: 0272-8087
1098-8971
العلاقة: Seminars in liver disease, 2019, 39 (1), pp. 13 - 25; https://repository.icr.ac.uk/handle/internal/3190Test
DOI: 10.1055/s-0038-1676097
الإتاحة: https://doi.org/10.1055/s-0038-1676097Test
https://repository.icr.ac.uk/handle/internal/3190Test
حقوق: https://www.rioxx.net/licenses/under-embargo-all-rights-reservedTest
رقم الانضمام: edsbas.CE4D409D
قاعدة البيانات: BASE
الوصف
تدمد:02728087
10988971
DOI:10.1055/s-0038-1676097